239 related articles for article (PubMed ID: 21658626)
1. New agents in follicular lymphoma.
Cheson BD
Best Pract Res Clin Haematol; 2011 Jun; 24(2):305-12. PubMed ID: 21658626
[TBL] [Abstract][Full Text] [Related]
2. Targeted treatment and new agents in follicular lymphoma.
Cheson BD
Int J Hematol; 2010 Jul; 92(1):5-11. PubMed ID: 20574673
[TBL] [Abstract][Full Text] [Related]
3. Translational development of vaccination strategies in follicular NHL.
Sakamaki I; Qin H; Kwak LW
Best Pract Res Clin Haematol; 2011 Jun; 24(2):295-304. PubMed ID: 21658625
[TBL] [Abstract][Full Text] [Related]
4. Treatment strategies in advanced stage follicular lymphoma.
van Oers MH; Kersten MJ
Best Pract Res Clin Haematol; 2011 Jun; 24(2):187-201. PubMed ID: 21658618
[TBL] [Abstract][Full Text] [Related]
5. Classification updates and clinical investigations in indolent non-Hodgkin lymphoma.
Cheson BD
Clin Adv Hematol Oncol; 2008 Sep; 6(9):4-6. PubMed ID: 18998258
[No Abstract] [Full Text] [Related]
6. Bendamustine's emerging role in the management of lymphoid malignancies.
Rummel MJ; Gregory SA
Semin Hematol; 2011 Apr; 48 Suppl 1():S24-36. PubMed ID: 21530769
[TBL] [Abstract][Full Text] [Related]
7. Novel antibodies against follicular non-Hodgkin's lymphoma.
van Meerten T; Hagenbeek A
Best Pract Res Clin Haematol; 2011 Jun; 24(2):231-56. PubMed ID: 21658621
[TBL] [Abstract][Full Text] [Related]
8. Treatment of mantle cell lymphoma: targeting the microenvironment.
Drach J; Seidl S; Kaufmann H
Expert Rev Anticancer Ther; 2005 Jun; 5(3):477-85. PubMed ID: 16001955
[TBL] [Abstract][Full Text] [Related]
9. New drugs for myeloma.
Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K
Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058
[TBL] [Abstract][Full Text] [Related]
10. Biological therapy doublets: pairing rituximab with interferon, lenalidomide, and other biological agents in patients with follicular lymphoma.
Kimby E
Curr Hematol Malig Rep; 2012 Sep; 7(3):221-7. PubMed ID: 22895878
[TBL] [Abstract][Full Text] [Related]
11. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
Robak T; Lech-Maranda E; Robak P
Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
[TBL] [Abstract][Full Text] [Related]
12. Development of rituximab-resistant B-NHL clones: an in vitro model for studying tumor resistance to monoclonal antibody-mediated immunotherapy.
Jazirehi AR; Bonavida B
Methods Mol Biol; 2011; 731():407-19. PubMed ID: 21516425
[TBL] [Abstract][Full Text] [Related]
13. Understanding novel therapeutic agents for multiple myeloma.
Tariman JD
Clin J Oncol Nurs; 2003; 7(5):521-8. PubMed ID: 14603548
[TBL] [Abstract][Full Text] [Related]
14. Lenalidomide and thalidomide: mechanisms of action--similarities and differences.
Anderson KC
Semin Hematol; 2005 Oct; 42(4 Suppl 4):S3-8. PubMed ID: 16344099
[TBL] [Abstract][Full Text] [Related]
15. Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma.
Dennie TW; Kolesar JM
Clin Ther; 2009; 31 Pt 2():2290-311. PubMed ID: 20110042
[TBL] [Abstract][Full Text] [Related]
16. Biology and treatment of follicular lymphoma.
Piccaluga PP; Sapienza MR; Agostinelli C; Sagramoso C; Mannu C; Sabattini E; Zinzani PL; Pileri SA
Expert Rev Hematol; 2009 Oct; 2(5):533-47. PubMed ID: 21083019
[TBL] [Abstract][Full Text] [Related]
17. Follicular lymphoma: emerging therapeutic strategies.
Kenkre VP; Kahl BS
Expert Rev Hematol; 2010 Aug; 3(4):485-95. PubMed ID: 21083037
[TBL] [Abstract][Full Text] [Related]
18. Use of bortezomib in B-cell non-Hodgkin's lymphoma.
Wang M; Zhou Y; Zhang L; Nguyen CA; Romaguera J
Expert Rev Anticancer Ther; 2006 Jul; 6(7):983-91. PubMed ID: 16831071
[TBL] [Abstract][Full Text] [Related]
19. Time to treatment response in patients with follicular lymphoma treated with bortezomib is longer compared with other histologic subtypes.
O'Connor OA; Portlock C; Moskowitz C; Hamlin P; Straus D; Gerecitano J; Gonen M; Dumitrescu O; Sarasohn D; Butos J; Neylon E; Mac-Gregor Cortelli B; Blumel S; Evens AM; Zelenetz AD; Wright J; Cooper B; Winter J; Vose J
Clin Cancer Res; 2010 Jan; 16(2):719-26. PubMed ID: 20068103
[TBL] [Abstract][Full Text] [Related]
20. [Current development of new drugs in malignant lymphoma].
Ogura M
Nihon Rinsho; 2012 Apr; 70 Suppl 2():715-30. PubMed ID: 23134034
[No Abstract] [Full Text] [Related]
[Next] [New Search]
